OTC Ocumetics Technology Corp.
Ocumetics Technology Corp. engages in research, development, production, and sale of vision enhancement products in Canada. It develops expandable intraocular lenses to eliminate the need for corrective lenses primarily for people over 45 years of age. The company was formerly known as Quantum Blockchain Technologies Ltd. and changed its name to Ocumetics Technology Corp. in August 2021. The company was founded in 2012 and is headquartered in Calgary, Canada.…
Industry Peers
Medical Instruments & SuppliesKey Statistics
About Ocumetics Technology (CVE: OTC)
›
Ocumetics Technology (CVE: OTC) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector.
The shares were at 0.3750 CAD on 19 November 2026, down 60.1% over 52 weeks. Its 52-week range is 0.3500 CAD to 0.9500 CAD: the price is 60.5% below the high and 7.1% above the low.
Its market capitalisation is 48.76M CAD.
Ocumetics Technology reports return on equity of 136.2% and an operating margin of 0.0%.
Its debt exceeds its cash by 4.22M CAD. Its Piotroski F-score is 1 out of 9, a weak reading of its financial health. The next earnings report is expected on 24 November 2026.